English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Mar 30, 2026

FDA grants accelerated approval to Denali’s Avlayah for Hunter syndrome
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Beam Therapeutics reports positive data for base editor in alpha-1 antitrypsin deficiency
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

BioSpace survey finds leadership more likely than managers to drive employee departures
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Maze Therapeutics shares fall after mixed results in kidney disease drug trial
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Indiana life sciences industry reports growth and new investments in 2026
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Wave Life Sciences shares fall after higher dose obesity trial data disappoints analysts
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

University of Chicago and IDefine launch research program to develop Kleefstra syndrome treatment
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Study finds low male fertility knowledge among adult men, especially non-medical backgrounds

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes